Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECLAIIM: Hizentra (IgPro20) in Adults with Dermatomyositis
jRCT2080224869Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Sep 2019
01
Overview
Phase 3, randomised, double-blind trial in dermatomyositis (DM) comparing IgPro20 (Hizentra) with Placebo (2% human albumin solution) (2 arms). Started Sep 2019; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
dermatomyositis (DM)
Beyond the preview
Go deeper on jRCT2080224869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224869.